Acquired factor V inhibitor in a case of pediatric venous thrombosis
Background: The development of acquired factor (F)V with inhibitor (AFVwI) is rare, resulting mainly in bleeding complications, although sporadic cases of thrombosis in adults have been reported. Key Clinical Question: How do you diagnose and manage a pediatric case of acute deep venous thrombosis a...
Saved in:
Main Authors: | Sweta Gupta, Matthew W. Bunce, Emily A. Cid, Rodney M. Camire, Amy D. Shapiro |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037924003418 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The anticoagulant effects of milvexian, a novel small molecule factor XIa inhibitor, are neutralized by activated prothrombin complex concentrates and recombinant factor VIIa in human plasma and whole blood in vitro
by: Matthew Bunce, et al.
Published: (2024-11-01) -
Assessing the Comparative Efficacy and Safety of Warfarin and Rivaroxaban for Cancer Associated Thrombosis: Experience From a Resource Limited Setting
by: Abel Tenaw Tasamma, et al.
Published: (2025-01-01) -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
by: Lucio Amitrano, et al.
Published: (2009-11-01) -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
by: Maria Anna Guardascione, et al.
Published: (2009-11-01) -
Anticoagulation Status and Outcome in Cerebral Venous Thrombosis: A Single-Center Retrospective Study from South India
by: Deepak Menon, et al.
Published: (2024-12-01)